RECURRENT NASOPHARYNGEAL CARCINOMA
Clinical trials for RECURRENT NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double immunotherapy may stall return of rare nasal cancer
Disease control Recruiting nowThis study is for people with a type of nose and throat cancer (nasopharyngeal carcinoma) that has come back or spread. After initial treatment with chemotherapy and the immunotherapy drug nivolumab, participants will receive either nivolumab alone or nivolumab plus another drug …
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:42 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: drug combo trial launches
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer that has returned or spread and no longer responds to standard treatments. It tests whether adding a targeted drug (cabozantinib) to two immunotherapy drugs (nivolumab and ipilimumab) can help shrink or stabilize the ca…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Proton beam takes aim at returning throat cancer
Disease control Recruiting nowThis study is testing a precise type of radiation called proton therapy for people whose nasopharyngeal cancer has come back. The goal is to see if it can control the cancer while causing fewer severe side effects than standard treatments. About 52 adults with recurrent, non-spre…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Immunotherapy boosts standard care for returning throat cancer
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (PD-1 antibody) to standard chemoradiotherapy helps people with recurrent nasopharyngeal cancer live longer. About 212 adults whose cancer has returned after prior treatment and who cannot have surgery will be randomly assigne…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New Low-Temperature surgery could improve survival in recurrent nasal cancer
Disease control Recruiting nowThis study compares two surgical techniques for people whose nasopharyngeal cancer has come back after initial treatment. Half the participants will receive a newer, low-temperature plasma ablation, while the other half will receive standard high-frequency electrocautery. The goa…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 18, 2026 12:01 UTC